Summary:
Click image to enlargeA phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK's meningococcal Group B and combined ABCWY vaccines when administered to healthy adolescents and young adults.
Qualified Participants Must:
• Healthy subjects between the ages of 10-25
• Subjects who are unvaccinated with MenACWY or received a single previous dose 4 yrs prior
Qualified Participants May Receive:
Health Checks, Assessments & Physical Examinations in relation to study at no cost to you; Compensation for qualifying participants